(2R,3R,4R,5R,7S)-3-(bromomethyl)-5-chloro-7-[(Z)-1-chlorohex-3-en-5-ynyl]-2-ethyloxepan-4-ol

Details

Top
Internal ID 2db08bbd-cbb1-4e50-84c6-3b9df4cacccd
Taxonomy Organoheterocyclic compounds > Oxepanes
IUPAC Name (2R,3R,4R,5R,7S)-3-(bromomethyl)-5-chloro-7-[(Z)-1-chlorohex-3-en-5-ynyl]-2-ethyloxepan-4-ol
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C15H21BrCl2O2/c1-3-5-6-7-11(17)14-8-12(18)15(19)10(9-16)13(4-2)20-14/h1,5-6,10-15,19H,4,7-9H2,2H3/b6-5-/t10-,11?,12+,13+,14-,15+/m0/s1
InChI Key MFEVKEHDTZDLJG-CFXZXSRLSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H21BrCl2O2
Molecular Weight 384.10 g/mol
Exact Mass 382.01020 g/mol
Topological Polar Surface Area (TPSA) 29.50 Ų
XlogP 4.20
Atomic LogP (AlogP) 3.72
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3R,4R,5R,7S)-3-(bromomethyl)-5-chloro-7-[(Z)-1-chlorohex-3-en-5-ynyl]-2-ethyloxepan-4-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9849 98.49%
Caco-2 - 0.5185 51.85%
Blood Brain Barrier + 0.7750 77.50%
Human oral bioavailability - 0.6286 62.86%
Subcellular localzation Mitochondria 0.6325 63.25%
OATP2B1 inhibitior - 0.8567 85.67%
OATP1B1 inhibitior + 0.8409 84.09%
OATP1B3 inhibitior + 0.9375 93.75%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.6800 68.00%
P-glycoprotein inhibitior - 0.8278 82.78%
P-glycoprotein substrate - 0.7520 75.20%
CYP3A4 substrate + 0.5792 57.92%
CYP2C9 substrate - 0.8071 80.71%
CYP2D6 substrate - 0.8019 80.19%
CYP3A4 inhibition - 0.6841 68.41%
CYP2C9 inhibition - 0.6816 68.16%
CYP2C19 inhibition - 0.5000 50.00%
CYP2D6 inhibition - 0.8682 86.82%
CYP1A2 inhibition - 0.6553 65.53%
CYP2C8 inhibition - 0.6334 63.34%
CYP inhibitory promiscuity - 0.5728 57.28%
UGT catelyzed - 0.5000 50.00%
Carcinogenicity (binary) - 0.6246 62.46%
Carcinogenicity (trinary) Danger 0.4951 49.51%
Eye corrosion - 0.9050 90.50%
Eye irritation - 0.9917 99.17%
Skin irritation - 0.6187 61.87%
Skin corrosion - 0.7809 78.09%
Ames mutagenesis + 0.5400 54.00%
Human Ether-a-go-go-Related Gene inhibition - 0.3852 38.52%
Micronuclear - 0.7267 72.67%
Hepatotoxicity + 0.5375 53.75%
skin sensitisation - 0.6181 61.81%
Respiratory toxicity - 0.5222 52.22%
Reproductive toxicity - 0.5286 52.86%
Mitochondrial toxicity - 0.7000 70.00%
Nephrotoxicity - 0.5898 58.98%
Acute Oral Toxicity (c) III 0.5778 57.78%
Estrogen receptor binding + 0.7592 75.92%
Androgen receptor binding - 0.6779 67.79%
Thyroid receptor binding + 0.6381 63.81%
Glucocorticoid receptor binding + 0.6096 60.96%
Aromatase binding - 0.6798 67.98%
PPAR gamma - 0.7074 70.74%
Honey bee toxicity - 0.7438 74.38%
Biodegradation - 0.6000 60.00%
Crustacea aquatic toxicity + 0.6400 64.00%
Fish aquatic toxicity + 0.9206 92.06%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.48% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 96.47% 95.93%
CHEMBL221 P23219 Cyclooxygenase-1 95.23% 90.17%
CHEMBL218 P21554 Cannabinoid CB1 receptor 93.18% 96.61%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 91.75% 96.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 90.39% 97.25%
CHEMBL3401 O75469 Pregnane X receptor 89.26% 94.73%
CHEMBL1951 P21397 Monoamine oxidase A 89.16% 91.49%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.44% 97.09%
CHEMBL2581 P07339 Cathepsin D 85.45% 98.95%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 84.95% 98.75%
CHEMBL5608 Q16288 NT-3 growth factor receptor 80.01% 95.89%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 14803851
LOTUS LTS0223164
wikiData Q105162601